Business Description
Panaxia Labs Israel Ltd
ISIN : IL0011043630
Compare
Compare
Traded in other countries / regions
PNAX.Israel IPO Date
2007-06-05Description
Panaxia Labs Israel Ltd is engaged in the manufacture and distribution of medical cannabis products. The firm offers a wide range of products comprising oral tablets, sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -6.79 | |||||
| Debt-to-Equity | -1.02 | |||||
| Debt-to-EBITDA | -1.94 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -70.46 | |||||
| Beneish M-Score | -19.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -37.6 | |||||
| 3-Year EBITDA Growth Rate | 45.6 | |||||
| 3-Year EPS without NRI Growth Rate | 34.8 | |||||
| 3-Year FCF Growth Rate | 77.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.3 | |||||
| 9-Day RSI | 28.81 | |||||
| 14-Day RSI | 37.31 | |||||
| 6-1 Month Momentum % | 46.36 | |||||
| 12-1 Month Momentum % | 58.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | |||||
| Quick Ratio | 0.13 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 80.73 | |||||
| Days Sales Outstanding | 149.8 | |||||
| Days Payable | 110.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.2 | |||||
| Shareholder Yield % | -82.97 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -93.31 | |||||
| Operating Margin % | -129.12 | |||||
| Net Margin % | -157.37 | |||||
| FCF Margin % | -67.35 | |||||
| ROA % | -114.32 | |||||
| ROIC % | -68.97 | |||||
| ROC (Joel Greenblatt) % | -470.23 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.75 | |||||
| EV-to-EBIT | -1.96 | |||||
| EV-to-EBITDA | -2.57 | |||||
| EV-to-Revenue | 2.98 | |||||
| EV-to-FCF | -4.45 | |||||
| Earnings Yield (Greenblatt) % | -51.12 | |||||
| FCF Yield % | -89.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Panaxia Labs Israel Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 16.217 | ||
| EPS (TTM) (₪) | -170 | ||
| Beta | 0 | ||
| Volatility % | 220.59 | ||
| 14-Day RSI | 37.31 | ||
| 14-Day ATR (₪) | 12.567693 | ||
| 20-Day SMA (₪) | 116.869 | ||
| 12-1 Month Momentum % | 58.27 | ||
| 52-Week Range (₪) | 1 - 171.7 | ||
| Shares Outstanding (Mil) | 0.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Panaxia Labs Israel Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Panaxia Labs Israel Ltd Stock Events
| Event | Date | Price(₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
Panaxia Labs Israel Ltd Frequently Asked Questions
What is Panaxia Labs Israel Ltd(XTAE:PNAX)'s stock price today?
The current price of XTAE:PNAX is ₪81.16. The 52 week high of XTAE:PNAX is ₪171.70 and 52 week low is ₪1.00.
When is next earnings date of Panaxia Labs Israel Ltd(XTAE:PNAX)?
The next earnings date of Panaxia Labs Israel Ltd(XTAE:PNAX) is .
Does Panaxia Labs Israel Ltd(XTAE:PNAX) pay dividends? If so, how much?
Panaxia Labs Israel Ltd(XTAE:PNAX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers